Estimating the undetected burden and the likelihood of strain persistence of drug-resistant <i>Neisseria gonorrhoeae</i>

Neisseria gonorrhoeae has developed resistance to all antibiotics recommended for treatment, and reports of reduced susceptibility to ceftriaxone, the last-line treatment, are increasing. Because many asymptomatic infections remain undiagnosed and most diagnosed infections do not undergo antibiotic susceptibility testing, surveillance systems may underestimate resistant infections. In this modeling study, we simulated the spread of a new strain of ceftriaxone-nonsusceptible N. gonorrhoeae in a population comprising men who have sex with men as well as heterosexual men and women. We compared scenarios with varying strain characteristics and surveillance capacity. For each scenario, we estimated 1) the number of undetected infections of the novel strain and 2) the likelihood of strain persistence in the absence of newly reported cases. Upon detection of 1 nonsusceptible isolate, the undetected burden was an estimated 5.4 infections with substantial uncertainty (95% uncertainty interval, 0-18 infections). Without additional reports of nonsusceptible infections over the subsequent 180 days, the estimate declined to 2.5 infections (95% uncertainty interval, 0-10). The likelihood of ongoing transmission also declined from 66% (95% uncertainty interval, 26-86) at first detection to 2% (95% uncertainty interval, 0-10) after 180 days. To extend the useful lifespan of last-line antibiotics, our model estimated the infection landscapes that could underlie data from surveillance systems.

Authors

Institutions

Publication Details

Journal
American Journal of Epidemiology
Published
2024-12-13
DOI
https://doi.org/10.1093/aje/kwae455
Citations
1
Primary Topic
Reproductive tract infections research
Type
article
Field-Weighted Citation Impact
0.34

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Estimating the undetected burden and the likelihood of strain persistence of drug-resistant Neisseria gonorrhoeae

Katherine Hsu, Yonatan H. Grad, Thomas L. Gift, Minttu M. Rönn et al.
1 citations
American Journal of Epidemiology
Reproductive tract infections research
0.34
article

Estimating the undetected burden and the likelihood of strain persistence of drug-resistant Neisseria gonorrhoeae

Katherine Hsu, Yonatan H. Grad, Thomas L. Gift, Minttu M. Rönn, Joshua A. Salomon, Kathleen Roosevelt, Heather Elder, Kirstin Roster
article en
1 citations

Abstract

Neisseria gonorrhoeae has developed resistance to all antibiotics recommended for treatment, and reports of reduced susceptibility to ceftriaxone, the last-line treatment, are increasing. Because many asymptomatic infections remain undiagnosed and most diagnosed infections do not undergo antibiotic susceptibility testing, surveillance systems may underestimate resistant infections. In this modeling study, we simulated the spread of a new strain of ceftriaxone-nonsusceptible N. gonorrhoeae in a population comprising men who have sex with men as well as heterosexual men and women. We compared scenarios with varying strain characteristics and surveillance capacity. For each scenario, we estimated 1) the number of undetected infections of the novel strain and 2) the likelihood of strain persistence in the absence of newly reported cases. Upon detection of 1 nonsusceptible isolate, the undetected burden was an estimated 5.4 infections with substantial uncertainty (95% uncertainty interval, 0-18 infections). Without additional reports of nonsusceptible infections over the subsequent 180 days, the estimate declined to 2.5 infections (95% uncertainty interval, 0-10). The likelihood of ongoing transmission also declined from 66% (95% uncertainty interval, 26-86) at first detection to 2% (95% uncertainty interval, 0-10) after 180 days. To extend the useful lifespan of last-line antibiotics, our model estimated the infection landscapes that could underlie data from surveillance systems.

American Journal of EpidemiologyVol. 194(10)
Boston Medical Center (US), Centers for Disease Control and Prevention (US), Massachusetts Department of Public Health (US), Harvard University (US), Centers for Disease Control and Prevention (UG), Stanford Health Care (US), Centers for Disease Control and Prevention (KE), Harvard Global Health Institute (US), Stanford University (US)
Centers for Disease Control and Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Good health and well-being
Openalex Percentile: Top 34%
Reproductive tract infections research
0.34
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.